Robocath is a french medtech which designs, develops and commercializes robotic solutions to treat cardiovascular diseases. R-One™ is the first european robotic-assisted solution for PCI. The company obtained the CE-mark for R-One™ in February 2019. It is designed to operate with precision and perform specific movements creating better interventional conditions (radioprotection). Thanks to its open architecture, R-One™ is compatible with market leading devices and cath labs. Robocath aims to become the world leader in vascular robotics and develop the remote treatment of vascular emergencies, guaranteeing the best care pathway for all. We are convinced that the future standard for minimally-invasive procedures is robot-based.